Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Proteomics and the promise of ‘enriching’ clinical trials

Swiss pharma giant Roche is working with proteomics specialists Biognosys and Caprion on introducing ‘clinical proteomics’ to clinical trials. This could help identify or measure new biomarkers and work out why a particular intervention is or isn’t working. So what’s the potential for ‘enriching’ clinical trials?

Download our 2019 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top